Fritextsökning
Innehållstyper
-
Meribel Pharma Solna
-
Metabolon
-
Partial court victory for entrepreneur who lost his company
Swedish life science entrepreneur Mikael Kubista has won the first round against a law firm that he, along with other co-owners, sued for negligent advice in co...
-
Lilly recruits top Swedish researcher in Alzheimer´s
One of Sweden's leading Alzheimer's researchers, Oskar Hansson, has been recruited by pharma giant Eli Lilly and will be moving to the USA.
-
RegFile AB
-
Trends and overview: ELRIG "Robotics and Automation"
Laboratories on the way to end-to-end automation: Robotics, artificial intelligence and automation technology boosted by pandemic
-
New Horizons in Biologics & Bioprocessing incl. Advanced Therapies: Stockholm (2026)
-
Sahlgrenska Science Park
-
LINK Medical Research
-
Kompauto Nordic AB
-
Merck Life Science A/S
-
Medicon Village Science Park
-
Bio-Works
-
Ready-to-install solutions for the lab-on-a-chip
Design for manufacturing lab-on-a-chip devices Reducing time-to-market together
-
Hypothesis testing versus conspiracy theory
"How do you know what is a conspiracy theory and what is a reasonable, scientifically based conclusion?" In a column, Ingrid Lönnstedt reflects on this question.
-
Large study on milk: Risky for women but not for men
The risk of ischemic heart disease (IHD) and acute myocardial infarction (MI) increased for women with milk intake levels higher than 2 glasses per day, while n...
-
Xbrane enters licensing agreement with Indian generics giant
Swedish biosimilar developer Xbrane Biopharma and the Indian company Intas Pharmaceuticals have entered into a license and co-development agreement.
-
Eli Lilly värvar toppforskaren Kaj Blennow – ska leda Alzheimerprojekt
Eli Lilly rekryterar Kaj Blennow, en av Sveriges och världens främsta forskare inom Alzheimers sjukdom, till en post som Vice President of Neuroscience Biomarker Development.
-
Festo AB
-
Novo Nordisk to invest billions in new quality control lab
Novo Nordisk has announced plans to invest 2.9 billion Danish kroner in order to establish a new quality control laboratory in Hillerød in northern Zealand, Denmark.
-
Quotient Sciences Limited
-
New cell therapy raises hope for curing type 1 diabetes – "Never succeeded before"
For the first time, a patient with type 1 diabetes has undergone an islet transplantation using genetically modified insulin-producing cells that do not require...
-
Galenica AB
-
Affibody AB